Chemed CHE Deferred Compensation Payable In Company Stock
Deferred Compensation Payable In Company Stock at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept che:DeferredCompensationPayableInCompanyStock.
The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's deferred compensation payable in company stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Chemed's deferred compensation payable in company stock?
- Chemed (CHE) reported deferred compensation payable in company stock of $2.4M in Q1 2026.
- How has Chemed's deferred compensation payable in company stock changed year-over-year?
- Chemed's deferred compensation payable in company stock increased by 6.0% year-over-year, from $2.26M to $2.4M.
- What is the long-term trend for Chemed's deferred compensation payable in company stock?
- Over 5 years (2020 to 2025), Chemed's deferred compensation payable in company stock has grown at a 0.1% compound annual growth rate (CAGR), from $2.34M to $2.36M.
- What does deferred compensation payable in company stock mean?
- This represents the portion of deferred compensation obligations that will be settled through the issuance of company equity rather than cash. By utilizing stock for settlement, the company preserves cash liquidity while aligning employee interests with shareholder value. It is a key indicator of how equity-based compensation structures impact the company's capital base.